Risk of bladder cancer among diabetic patients treated with pioglitazone: interim report of a longitudinal cohort study. - Wikidata - wikimedia - TriplyDB

Risk of bladder cancer among diabetic patients treated with pioglitazone: interim report of a longitudinal cohort study.

Risk of bladder cancer among diabetic patients treated with pioglitazone: interim report of a longitudinal cohort study.

http://www.wikidata.org/entity/Q34628009

about

Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).Pioglitazone for adults with high risk of developing type 2 diabetes mellitus Pioglitazone for people with impaired glucose tolerance or impaired fasting blood glucose Pioglitazone for people with impaired glucose tolerance or impaired fasting blood glucose Non-alcoholic fatty liver disease: what the clinician needs to know.Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline Getting 'Smad' about obesity and diabetes Unexploited Antineoplastic Effects of Commercially Available Anti-Diabetic Drugs Pharmacogenetics in type 2 diabetes: influence on response to oral hypoglycemic agents Nonalcoholic steatohepatitis: emerging targeted therapies to optimize treatment options Diabetes and cancer: two diseases with obesity as a common risk factor Current perspectives in bladder cancer management Non-alcoholic fatty liver disease and diabetes: from physiopathological interplay to diagnosis and treatment Systematic reviews to ascertain the safety of diabetes medications Cancer risk for patients using thiazolidinediones for type 2 diabetes: a meta-analysis Diagnosing and managing diabetes in HIV-infected patients: current concepts Clinical utility in the treatment of type 2 diabetes with the saxagliptin/metformin fixed combination β-cell dysfunction: Its critical role in prevention and management of type 2 diabetes.Clinical assessment of hepatic de novo lipogenesis in non-alcoholic fatty liver disease Update on the treatment of type 2 diabetes mellitus Recent advances in understanding/management of non-alcoholic steatohepatitis.Unmasking differential effects of rosiglitazone and pioglitazone in the combination treatment with n-3 fatty acids in mice fed a high-fat diet A novel mechanism of PPAR gamma induction via EGFR signalling constitutes rational for combination therapy in bladder cancer The current role of thiazolidinediones in diabetes management.Rational therapy for diabetes: early recognition of adverse effects and avoidance of disruptive false alarms.Controversies in the Diagnosis and Management of NAFLD and NASH.Should all women with PCOS be treated for insulin resistance?Investigational anti-hyperglycemic agents: the future of type 2 diabetes therapy?Pioglitazone together with imatinib in chronic myeloid leukemia: A proof of concept study.Litigation seeking access to data from ongoing clinical trials: a threat to clinical research.Pioglitazone utilization, efficacy & safety in Indian type 2 diabetic patients: A systematic review & comparison with European Medicines Agency Assessment Report.Optimal therapy of type 2 diabetes: a controversial challenge Thiazolidinedione-independent activation of peroxisome proliferator-activated receptor γ is a potential target for diabetic macrovascular complications.Latest insights into the risk of cancer in diabetes Hyperglycemia, a neglected factor during cancer progression Minireview: Pathophysiological roles of the TR4 nuclear receptor: lessons learned from mice lacking TR4 Diabetes medications and cancer risk: review of the literature A retrospective study on finding correlation of pioglitazone and incidences of bladder cancer in the Indian population.Type 2 Diabetes Mellitus and Cancer: The Role of Pharmacotherapy.Data-driven prediction of adverse drug reactions induced by drug-drug interactions.

P2860

Q22241288-2F74F8A0-43BF-45EA-9FDD-159958BF3889 Q24187448-F0CCD09C-5C44-41B6-A3E4-F7E28D608B4F Q24195168-AC298942-AEAF-48A1-8F87-190467268D5C Q24202245-C18E014C-51A6-4BB4-8232-08951E8458B8 Q24563068-A66FD22D-7ABE-4529-BD5E-1CDE3405B3B8 Q24608464-E9D19F8A-6A9D-4D02-9D64-D801739E74CB Q24630117-A6C68B9C-7188-408F-B8E4-8A3A6B3F8F98 Q26750845-6209777D-B162-4450-B287-A7E3641F1CFA Q26751138-DD76EBF1-D847-4597-BD57-B656A020EAA5 Q26796448-5FA9B83F-04D8-418E-A15A-8EBBF1A5F23A Q26822753-B2D50BC7-3DC2-47EB-BEAA-3EF4C33ACE27 Q26824914-4B7768A5-01C0-4EC4-825B-32D857F89470 Q26852019-FCD6E24E-C2B1-4FCD-9AC7-03D97BA4AA0C Q27000766-30FDBEA4-C815-451B-96C3-EAB7A953B585 Q27002540-144E6E2C-48E7-4C0B-811B-C604915377F9 Q27014697-8E2A4813-A361-4613-9BF1-9965108FB938 Q27026211-17F61ED2-4D45-4823-8592-EEADE9061746 Q27692665-77C2BFF8-BE8F-4D6D-ABCB-B7DD1F8AFCF5 Q28072381-5E4DC95F-7EA3-4C2E-AD66-A4BA614D75D1 Q28073342-D60ABEB8-6AE5-459B-AE31-5E4C3F8A6AD6 Q28085689-15BA94F2-7E35-4533-AD95-D25CB29B43E1 Q28477781-A9BF22FE-D20F-45A6-83DF-3251C8BF59F7 Q28486089-00161FA0-B1C7-4F17-AEA2-03C6AAFBE11A Q30250347-FD0630D2-A809-485D-99A4-A8EA23546F18 Q30410721-6E274F08-1662-4CB5-BC4F-5F6092E81BBC Q30412296-7465F58A-5F44-45B8-AE5C-1BCB14567202 Q30423117-AE052F6F-B7ED-4BB3-BFA6-6770D8E13E5C Q30426407-9CBF2AF2-380B-45E3-8BB5-56D4851CF89A Q30490577-0F714E36-BC83-4E04-BDE1-3A9B4F677707 Q30837735-E929FEC7-AF87-42F0-91AC-CD263BD70347 Q33568852-5A6FD731-F7CD-490F-8263-F8BFC70C2D55 Q33577712-984FCF90-9E51-4072-AD04-C57937E4E9B0 Q33585657-5A8A5801-AAA2-4E51-87F7-B4704FE36198 Q33588852-F2D5B290-E519-4697-8263-08BABBB3B569 Q33594115-E2D93F6D-EDE5-43A0-A407-23718E9D61CF Q33701419-11A49A6B-FC91-4B27-A6D9-12145EF3CC0E Q33714881-1B3ED287-F4D9-400E-A469-AAFFADA42528 Q33750513-11F9B459-FB83-4E37-83C7-13EF5C84641F Q33756414-865B24D3-E712-411C-BDFA-D91C639CD79F Q33781632-BBEDEE4D-4C13-4EC7-AFB4-B344552C3369

P2860

Risk of bladder cancer among diabetic patients treated with pioglitazone: interim report of a longitudinal cohort study.

http://www.wikidata.org/entity/Q34628009

description

2011 nî lūn-bûn

@nan

2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Risk of bladder cancer among d ...... f a longitudinal cohort study.

@ast

Risk of bladder cancer among d ...... f a longitudinal cohort study.

@en

Risk of bladder cancer among d ...... f a longitudinal cohort study.

@nl

type

label

Risk of bladder cancer among d ...... f a longitudinal cohort study.

@ast

Risk of bladder cancer among d ...... f a longitudinal cohort study.

@en

Risk of bladder cancer among d ...... f a longitudinal cohort study.

@nl

prefLabel

Risk of bladder cancer among d ...... f a longitudinal cohort study.

@ast

Risk of bladder cancer among d ...... f a longitudinal cohort study.

@en

Risk of bladder cancer among d ...... f a longitudinal cohort study.

@nl

P1433

Q34628009-1C931B25-EED2-4041-908C-E6C51CA8B812

P1476

Q34628009-3964C3E5-1802-47C8-815E-CD140D01EEF3

P2093

Q34628009-37DFD66D-8387-4169-A690-7AD75E74CDE7

Q34628009-54055257-80B1-4683-A23A-5E2F06C009C1

Q34628009-555E00B0-E416-4172-91F5-0D1B4D0FF3E5

Q34628009-A4E668B3-0BC3-4E4A-A55D-8EBC1D8DD1EF

Q34628009-BDDE0636-2910-46E0-BAC5-06CF98B6F59C

Q34628009-CA339A32-98E8-471E-BA8E-9974845C0C85

Q34628009-D1FC8602-A1BB-421A-9ADC-17ADB50D1D8B

Q34628009-E4929315-0871-4C1B-BEB8-531B1F338E8D

Q34628009-F167BC93-90D0-4440-9763-15C5F7A93F9D

P2860

Q34628009-1370A4A3-9B8A-4EDA-9BC2-AAEF9220CBB8

Q34628009-1BE8E5D6-96DE-40F9-851D-54942A475FC3

Q34628009-2FC217F4-36E2-459B-BCC3-B68312FD9DFE

Q34628009-35BBFA19-626A-401B-8442-A4295E06F653

Q34628009-4901E6B3-CB56-45D4-A9C7-179A73709190

Q34628009-4C2003EC-D517-4E3B-8B19-532A5C38A971

Q34628009-525ABE10-CBA3-4300-9A0E-379CF0C47D76

Q34628009-5AA6E36D-FE1B-461D-BE09-51128014F075

Q34628009-746AC21D-2AA1-4EDD-917E-7DC17FD257CE

Q34628009-86EDCAA8-1C31-497C-8F78-F1D04244A4F7

P304

Q34628009-B7AC77E3-AD87-4FBE-8DDB-49971CB2D5B7

P31

Q34628009-2A1B1A39-0F65-4441-A548-21321AFA08D8

P356

Q34628009-1A3520D3-AE49-4EEC-B1AD-0DC1ECE91E38

P407

Q34628009-A65DEEB6-7F63-4742-A136-F2B10D3F5ACA

P433

Q34628009-F4A44775-F426-4782-A5AA-13050FE3A416

P478

Q34628009-B1692F79-72D8-4959-A420-B8C9ED3AD64E

P50

Q34628009-0EA4F413-A42D-436A-95E5-25ABF267F2D3

P577

Q34628009-89838BF1-540D-400C-84AC-E3F9FC8B34AF

P5875

Q34628009-3C8204AA-EBA1-49F0-B24F-6007500713E4

P698

Q34628009-AD365632-6985-40FD-8702-A16FE0E135E8

P921

Q34628009-2C168900-EDCD-449C-894A-95F773139C18

P932

Q34628009-3FF0292E-6611-4C6D-B4FB-C70161BBB78D

P356

P1433

P1476

Risk of bladder cancer among d ...... of a longitudinal cohort study

@en

P2093

Brian L Strom

http://www.w3.org/2001/XMLSchema#string

Charles P Quesenberry

http://www.w3.org/2001/XMLSchema#string

David J Vaughn

http://www.w3.org/2001/XMLSchema#string

James D Lewis

http://www.w3.org/2001/XMLSchema#string

Joseph Selby

http://www.w3.org/2001/XMLSchema#string

Lisa Nessel

http://www.w3.org/2001/XMLSchema#string

Monique Hedderson

http://www.w3.org/2001/XMLSchema#string

Tiffany Peng

http://www.w3.org/2001/XMLSchema#string

Warren B Bilker

http://www.w3.org/2001/XMLSchema#string

P2860

Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes

Role of peroxisome proliferator-activated receptor gamma and its ligands in non-neoplastic and neoplastic human urothelial cells

Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice

Metformin and reduced risk of cancer in diabetic patients

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

The influence of glucose-lowering therapies on cancer risk in type 2 diabetes.

Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor.

Effects of PPARgamma and combined agonists on the urinary tract of rats and other species.

Diabetes mellitus and risk of bladder cancer: a meta-analysis.

Rosiglitazone and risk of cancer: a meta-analysis of randomized clinical trials

P304

916-922

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DC10-1068

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P50

Assiamira Ferrara

P577

2011-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50907243

http://www.w3.org/2001/XMLSchema#string

P698

21447663

http://www.w3.org/2001/XMLSchema#string

P921

P932

3064051

http://www.w3.org/2001/XMLSchema#string